TNF Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Recent Developments, Liquidity and Management's Plans - Summary of Milestone Events Payment (Details) (Parenthetical)	3 Months Ended
	Mar. 31, 2021 USD ($) Integer
Number of consecutive trading days \| Integer	10
Milestone Period One [Member]
Number of trading days \| Integer	10
Number of consecutive trading days \| Integer	20
Market capitalization	$ 500,000,000
Payments to milestone	$ 20,000,000
Milestone Period Two [Member]
Number of trading days \| Integer	10
Number of consecutive trading days \| Integer	20
Increase in market capitalization	$ 250,000,000
Incremental increase payable	20,000,000
Milestone Period Two [Member] \| Maximum [Member]
Market capitalization	1,000,000,000
Payments to milestone	$ 10,000,000
Milestone Period Three [Member]
Number of trading days \| Integer	10
Number of consecutive trading days \| Integer	20
Market capitalization	$ 1,000,000,000
Payments to milestone	$ 25,000,000
Milestone Period Four [Member]
Number of trading days \| Integer	10
Number of consecutive trading days \| Integer	20
Increase in market capitalization	$ 1,000,000,000
Milestone Period Four [Member] \| Maximum [Member]
Payments to milestone	$ 25,000,000